Enlivex Therapeutics Ltd. buy Liberte
Start price
03.10.20
/
50%
€11.30
Target price
04.11.21
-
Performance (%)
-43.36%
End price
20.07.21
€6.40
Summary
This prediction ended on 20.07.21 with a price of €6.40. The BUY prediction by Liberte for Enlivex Therapeutics Ltd. performed very badly with a performance of -43.36%. Liberte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Enlivex Therapeutics Ltd. | -9.392% | -9.392% | 32.258% | -29.915% |
| iShares Core DAX® | 0.625% | 4.952% | 8.658% | 63.690% |
| iShares Nasdaq 100 | 1.160% | -1.160% | 26.817% | 89.860% |
| iShares Nikkei 225® | 2.356% | -1.354% | 48.195% | 81.683% |
| iShares S&P 500 | 0.631% | 1.380% | 22.985% | 70.248% |
According to Liberte what are the pros and cons of Enlivex Therapeutics Ltd. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Liberte for this prediction
In the thread Enlivex Therapeutics Ltd. diskutieren
Buy Bio Blast Pharma Ltd